Ignite Creation Date:
2025-12-24 @ 11:53 PM
Ignite Modification Date:
2026-02-21 @ 11:36 PM
Study NCT ID:
NCT02194751
Status:
NOT_YET_RECRUITING
Last Update Posted:
2021-04-08
First Post:
2014-07-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Oncoquest-L Vaccine in Patients With Previously Untreated Stage III or IV, Asymptomatic, Non-bulky Follicular Lymphoma
Sponsor:
XEME Biopharma Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-07
Start Date Type:
ESTIMATED
Primary Completion Date:
2024-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-06
Completion Date Type:
ESTIMATED
First Submit Date:
2014-07-14
First Submit QC Date:
None
Study First Post Date:
2014-07-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-04-07
Last Update Post Date:
2021-04-08
Last Update Post Date Type:
ACTUAL